SecBot SecBot
SECBOTREPLAY Home › Report › KRYS

KRYS · Krystal Biotech insiders executed a cluster of trades over the past…

Krystal Biotech, Inc. · CLUSTER filed Feb 26, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 5/10

CLUSTER filed Feb 26, 2026 at 19:00 ET

Krystal Biotech insiders executed a cluster of trades over the past week, including open-market sales totaling $4.4 million. CEO Krish S. Krishnan and President of R&D Suma Krishnan exercised stock options (non-cash), while Chief Accounting Officer Kathryn Romano sold $200,700 worth of shares and also exercised options. Director Daniel Janney sold over $4.4 million in three transactions, representing the bulk of the activity.

  • Director Daniel Janney sold 15,233 shares in open-market transactions for $4.395 million over three days.
  • CEO Krish S. Krishnan and President of R&D Suma Krishnan exercised options for 8,750 and 22,500 shares respectively (non-cash events).
  • Chief Accounting Officer Kathryn Romano sold 750 shares for $200,700 and exercised 7,500 options (non-cash).
  • Total open-market sales in the cluster: $4.4 million.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access